Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03973918
Title Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG (BRAF)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

high grade glioma

pleomorphic xanthoastrocytoma

Therapies

Binimetinib + Encorafenib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST